Stock listing

VIRP Stock Price, News, Filings & Events — Virbac Sa

Selected listing: VIRP · EURONEXT · EUR · FR

This page tracks Virbac Sa's VIRP:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VIRP:EURONEXT. VIRP:EURONEXT is the stock-level entry point for investors researching Virbac Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Virbac Sa is a public company listed under the ticker VIRP, operating in the French market. The company has a market capitalization of approximately €3.19 billion. Virbac specializes in veterinary pharmaceuticals and is dedicated to improving animal health.

VIRP:EURONEXTEURFRUpdated September 5, 2026
Virbac Sa logo
Ticker
VIRP:EURONEXT
Asset type
Stock
Market cap
$3.13B
Sector
Health Technology
Industry
Biotechnology
Exchange
EURONEXT
Currency
EUR

Virbac Sa VIRP:EURONEXT stock context

This page tracks Virbac Sa's VIRP:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VIRP:EURONEXT. VIRP:EURONEXT is the stock-level entry point for investors researching Virbac Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Virbac Sa is a public company listed under the ticker VIRP, operating in the French market. The company has a market capitalization of approximately €3.19 billion. Virbac specializes in veterinary pharmaceuticals and is dedicated to improving animal health.

Latest news from Virbac Sa

All Virbac Sa news →

Research Virbac Sa

Alternate listings